Cepheid launches next-generation Xpert Flu diagnostic test
28 October 2013
Cepheid has launched its next generation Xpert Flu test for the
GeneXpert System, offering on-demand STAT testing for triage,
outbreaks, emergencies and high risk patient management.
The molecular diagnostic test, which has received the CE IVD
mark, is capable of providing on-demand results in just over an
hour. With faster turnaround times for improved workflows, plus
wider coverage, it enables real-time determination of Flu A and Flu
B infection, as well as the identification of 2009 H1N1, maximising
medical decision making. This leads to improved isolation and
infection control measures, enhancing patient flow and bed use, and
reducing the pressure on hospital resources.
Xpert Flu is a key component of Cepheid’s Winter Care Bundle,
comprising of the Xpert Flu, Xpert SA Nasal Complete, Xpert C.
difficile and Xpert Norovirus rapid tests, which are
aimed at helping hospitals manage highly transmissible infections
and reduce the potential for preventable ward closures.